Anti-EFHC2 monoclonal antibody

Pre-made anti-EFHC2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to EFHC2/EFHC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2470-Ab-1/ GM-Tg-hg-IP2470-Ab-2Anti-Human EFHC2 monoclonal antibodyHuman
GM-Tg-rg-IP2470-Ab-1/ GM-Tg-rg-IP2470-Ab-2Anti-Rat EFHC2 monoclonal antibodyRat
GM-Tg-mg-IP2470-Ab-1/ GM-Tg-mg-IP2470-Ab-2Anti-Mouse EFHC2 monoclonal antibodyMouse
GM-Tg-cynog-IP2470-Ab-1/ GM-Tg-cynog-IP2470-Ab-2Anti-Cynomolgus/ Rhesus macaque EFHC2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2470-Ab-1/ GM-Tg-felg-IP2470-Ab-2Anti-Feline EFHC2 monoclonal antibodyFeline
GM-Tg-cang-IP2470-Ab-1/ GM-Tg-cang-IP2470-Ab-2Anti-Canine EFHC2 monoclonal antibodyCanine
GM-Tg-bovg-IP2470-Ab-1/ GM-Tg-bovg-IP2470-Ab-2Anti-Bovine EFHC2 monoclonal antibodyBovine
GM-Tg-equg-IP2470-Ab-1/ GM-Tg-equg-IP2470-Ab-2Anti-Equine EFHC2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2470-Ab-1/ GM-Tg-hg-IP2470-Ab-2; GM-Tg-rg-IP2470-Ab-1/ GM-Tg-rg-IP2470-Ab-2;
GM-Tg-mg-IP2470-Ab-1/ GM-Tg-mg-IP2470-Ab-2; GM-Tg-cynog-IP2470-Ab-1/ GM-Tg-cynog-IP2470-Ab-2;
GM-Tg-felg-IP2470-Ab-1/ GM-Tg-felg-IP2470-Ab-2; GM-Tg-cang-IP2470-Ab-1/ GM-Tg-cang-IP2470-Ab-2;
GM-Tg-bovg-IP2470-Ab-1/ GM-Tg-bovg-IP2470-Ab-2; GM-Tg-equg-IP2470-Ab-1/ GM-Tg-equg-IP2470-Ab-2
Products NameAnti-EFHC2 monoclonal antibody
Formatmab
Target NameEFHC2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-EFHC2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2470-Ag-1Recombinant multi-species EFHC2/ MRX74/ dJ1158H2.1 protein


    Target information

    Target IDGM-IP2470
    Target NameEFHC2
    Gene ID80258,74405,302507,709087,480888,101087561,100336399,100059410
    Gene Symbol and Synonyms4933407D04Rik,dJ1158H2.1,EFHC2,mRib72-2,MRX74,RGD1563388
    Uniprot AccessionQ5JST6,A0A3Q1N1R0
    Uniprot Entry NameEFHC2_HUMAN,A0A3Q1N1R0_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000183690
    Target ClassificationN/A

    The target: EFHC2, gene name: EFHC2, also named as MRX74, dJ1158H2.1. This gene encodes a protein which contains three DM10 domains and three calcium-binding EF-hand motifs. A related protein is encoded by a gene on chromosome 6. It has been suggested that both proteins are involved in the development of epilepsy (PMID: 15258581, 16112844) and that this gene may be associated with fear recognition in individuals with Turner syndrome. [provided by RefSeq, Aug 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.